NuVasive Analysis
| NUVADelisted Stock | USD 42.35 0.85 1.97% |
NuVasive is overvalued with Real Value of 35.07 and Hype Value of 42.35. The main objective of NuVasive delisted stock analysis is to determine its intrinsic value, which is an estimate of what NuVasive is worth, separate from its market price. There are two main types of NuVasive's stock analysis: fundamental analysis and technical analysis.
The NuVasive stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NuVasive's ongoing operational relationships across important fundamental and technical indicators.
NuVasive |
NuVasive Stock Analysis Notes
About 100.0% of the company shares are owned by institutional investors. The book value of NuVasive was now reported as 17.02. The company had not issued any dividends in recent years. NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people. To find out more about NuVasive contact Christopher Barry at 858 909 1800 or learn more at https://www.nuvasive.com.NuVasive Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NuVasive's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NuVasive or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| NuVasive is not yet fully synchronised with the market data | |
| NuVasive has a very high chance of going through financial distress in the upcoming years | |
| Over 100.0% of the company shares are owned by institutional investors |
NuVasive Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to NuVasive previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of November 2023 Upcoming Quarterly Report | View | |
| 28th of February 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
NuVasive Thematic Classifications
In addition to having NuVasive stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ObamacareCompanies that count on Obamacare to take off |
NuVasive Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B.NuVasive Profitablity
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.NuVasive Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NuVasive insiders, such as employees or executives, is commonly permitted as long as it does not rely on NuVasive's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NuVasive insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Valentine Keith over a year ago Exercise or conversion by Valentine Keith of 2871 shares of NuVasive subject to Rule 16b-3 | ||
Wolterman Dan over a year ago Acquisition by Wolterman Dan of 4816 shares of NuVasive subject to Rule 16b-3 | ||
Dale Wolf over a year ago Exercise or conversion by Dale Wolf of 4572 shares of NuVasive subject to Rule 16b-3 |
NuVasive Outstanding Bonds
NuVasive issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NuVasive uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NuVasive bonds can be classified according to their maturity, which is the date when NuVasive has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NUTRIEN LTD 3 Corp BondUS67077MAD02 | View | |
| NUTRIEN LTD 4 Corp BondUS67077MAE84 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| NTRCN 395 13 MAY 50 Corp BondUS67077MAX65 | View | |
| NTRCN 595 07 NOV 25 Corp BondUS67077MAY49 | View | |
| NUTRIEN LTD Corp BondUS67077MAT53 | View | |
| NUTRIEN LTD Corp BondUS67077MAU27 | View | |
| NUTRIEN LTD 49 Corp BondUS67077MAR97 | View |
NuVasive Predictive Daily Indicators
NuVasive intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NuVasive stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About NuVasive Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NuVasive prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NuVasive shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as NuVasive. By using and applying NuVasive Stock analysis, traders can create a robust methodology for identifying NuVasive entry and exit points for their positions.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NuVasive to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |